My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alkermes plc - Ordinary Shares (NQ:ALKS)

27.63 -0.16 (-0.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,002,584
Open 27.87
Bid (Size) 27.50 (3)
Ask (Size) 27.66 (50)
Prev. Close 27.79
Today's Range 27.52 - 28.16
52wk Range 25.16 - 36.45
Shares Outstanding 166,121,384
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Deep Dive Into Alkermes Stock: Analyst Perspectives (7 Ratings)
 
Via Benzinga
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday
 
Via Benzinga

Performance

YTD
-3.9%
-3.9%
1 Month
-4.7%
-4.7%
3 Month
-5.6%
-5.6%
6 Month
-20.6%
-20.6%
1 Year
-1.7%
-1.7%

More News

Read More
This Unisys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
Bruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For July 29, 2025
Via Benzinga
Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Via Benzinga
Earnings Scheduled For May 1, 2025
Via Benzinga
NASDAQ:ALKS: good value for what you're paying.
Via Chartmill
ALKERMES PLC (NASDAQ:ALKS) Emerges as a Top Value Pick with Strong Fundamentals and Undervalued Metrics
Via Chartmill
Alkermes PLC (NASDAQ:ALKS) Surges 7.8% Pre-Market After Q2 2025 Earnings Beat Revenue and EPS Estimates
Via Chartmill
Topics Earnings
Alkermes Q2 Sales Up 14 Percent
Via The Motley Fool
Topics Intellectual Property
Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives.
Via Investor's Business Daily
Alkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study
Via Benzinga
Expert Outlook: Alkermes Through The Eyes Of 6 Analysts
Via Benzinga
Biogen Shares Slip After $46M Research Charge Hits Quarterly Profit
Via Stocktwits
ALKERMES PLC (NASDAQ:ALKS) – A Potential Undervalued Opportunity in Biopharma
Via Chartmill
Nvidia To Rally More Than 38%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
This Cooper Companies Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday
Via Benzinga
Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Via Benzinga
This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
Beyond The Numbers: 6 Analysts Discuss Alkermes Stock
Via Benzinga
In a market where value is scarce, ALKERMES PLC (NASDAQ:ALKS) offers a refreshing opportunity with its solid fundamentals.
Via Chartmill
What 5 Analyst Ratings Have To Say About Alkermes
Via Benzinga
Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?
Via Benzinga
Topics Economy
Alkermes Plc EPS Soars Past Forecasts
Via The Motley Fool

Frequently Asked Questions

Is Alkermes plc - Ordinary Shares publicly traded?
Yes, Alkermes plc - Ordinary Shares is publicly traded.
What exchange does Alkermes plc - Ordinary Shares trade on?
Alkermes plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alkermes plc - Ordinary Shares?
The ticker symbol for Alkermes plc - Ordinary Shares is ALKS on the Nasdaq Stock Market
What is the current price of Alkermes plc - Ordinary Shares?
The current price of Alkermes plc - Ordinary Shares is 27.63
When was Alkermes plc - Ordinary Shares last traded?
The last trade of Alkermes plc - Ordinary Shares was at 09/22/25 04:00 PM ET
What is the market capitalization of Alkermes plc - Ordinary Shares?
The market capitalization of Alkermes plc - Ordinary Shares is 4.59B
How many shares of Alkermes plc - Ordinary Shares are outstanding?
Alkermes plc - Ordinary Shares has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.